345 related articles for article (PubMed ID: 29761863)
1. Surgical treatment of esophageal cancer in the era of multimodality management.
Borggreve AS; Kingma BF; Domrachev SA; Koshkin MA; Ruurda JP; van Hillegersberg R; Takeda FR; Goense L
Ann N Y Acad Sci; 2018 Dec; 1434(1):192-209. PubMed ID: 29761863
[TBL] [Abstract][Full Text] [Related]
2. Optimal surgical approach for esophageal cancer in the era of minimally invasive esophagectomy and neoadjuvant therapy.
Noordman BJ; Wijnhoven BP; van Lanschot JJ
Dis Esophagus; 2016 Oct; 29(7):773-779. PubMed ID: 26382935
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.
Ikebe M; Morita M; Yamamoto M; Toh Y
Gen Thorac Cardiovasc Surg; 2016 Jul; 64(7):386-94. PubMed ID: 27165288
[TBL] [Abstract][Full Text] [Related]
4. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
[TBL] [Abstract][Full Text] [Related]
5. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Mariette C; Piessen G; Briez N; Triboulet JP
Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
[TBL] [Abstract][Full Text] [Related]
6. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
8. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.
Huddy JR; Huddy FMS; Markar SR; Tucker O
Dis Esophagus; 2018 Jan; 31(1):1-11. PubMed ID: 29024949
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
Motoyama S; Sato Y; Sasaki T; Wakita A; Kawakita Y; Liu J; Nagaki Y; Saito H; Imai K; Konno H; Mizusawa KT; Minamiya Y
Anticancer Res; 2017 Oct; 37(10):5837-5843. PubMed ID: 28982909
[TBL] [Abstract][Full Text] [Related]
10. Transhiatal Esophagectomy for Esophageal Cancer.
Namm JP; Posner MC
J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):752-756. PubMed ID: 27548444
[TBL] [Abstract][Full Text] [Related]
11. Lymph node dissection in surgical treatment of esophageal neoplasms.
Law S; Wong J
Surg Oncol Clin N Am; 2007 Jan; 16(1):115-31. PubMed ID: 17336240
[TBL] [Abstract][Full Text] [Related]
12. Predicting response to neoadjuvant therapy in esophageal cancer.
Vallböhmer D; Brabender J; Grimminger P; Schröder W; Hölscher AH
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1449-55. PubMed ID: 21929318
[TBL] [Abstract][Full Text] [Related]
13. Dissection of lymph node metastases in esophageal cancer.
Gockel I; Sgourakis G; Lyros O; Hansen T; Lang H
Expert Rev Anticancer Ther; 2011 Apr; 11(4):571-8. PubMed ID: 21504324
[TBL] [Abstract][Full Text] [Related]
14. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West.
Moaven O; Wang TN
Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037
[TBL] [Abstract][Full Text] [Related]
15. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
16. Future Perspectives of Surgery for Esophageal Cancer.
Kikuchi H; Takeuchi H
Ann Thorac Cardiovasc Surg; 2018 Oct; 24(5):219-222. PubMed ID: 29962387
[TBL] [Abstract][Full Text] [Related]
17. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer.
Shaikh T; Meyer JE; Horwitz EM
Surg Oncol Clin N Am; 2017 Jul; 26(3):405-429. PubMed ID: 28576180
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.
Mota FC; Cecconello I; Takeda FR; Tustumi F; Sallum RAA; Bernardo WM
Int J Surg; 2018 Jun; 54(Pt A):176-181. PubMed ID: 29730075
[TBL] [Abstract][Full Text] [Related]
19. [Lymph node involvement in œsophageal cancer: surgical approach].
Gronnier C; Mariette C
Cancer Radiother; 2014 Oct; 18(5-6):559-64. PubMed ID: 25195112
[TBL] [Abstract][Full Text] [Related]
20. Stage-directed individualized therapy in esophageal cancer.
Goense L; van Rossum PS; Kandioler D; Ruurda JP; Goh KL; Luyer MD; Krasna MJ; van Hillegersberg R
Ann N Y Acad Sci; 2016 Oct; 1381(1):50-65. PubMed ID: 27384385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
